FI860832A - Tiazolidinderivat, deras framstaellning och anvaendning. - Google Patents

Tiazolidinderivat, deras framstaellning och anvaendning. Download PDF

Info

Publication number
FI860832A
FI860832A FI860832A FI860832A FI860832A FI 860832 A FI860832 A FI 860832A FI 860832 A FI860832 A FI 860832A FI 860832 A FI860832 A FI 860832A FI 860832 A FI860832 A FI 860832A
Authority
FI
Finland
Prior art keywords
thiazolid
derivatives
deras framstaellning
framstaellning och
och anvaendning
Prior art date
Application number
FI860832A
Other languages
English (en)
Other versions
FI82693C (fi
FI82693B (fi
FI860832A0 (fi
Inventor
Takao Yoshioka
Eiichi Kitazawa
Tomoyuki Kurumada
Mitsuo Yamazaki
Kazuo Hasegawa
Takashi Fujita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI860832A0 publication Critical patent/FI860832A0/fi
Publication of FI860832A publication Critical patent/FI860832A/fi
Application granted granted Critical
Publication of FI82693B publication Critical patent/FI82693B/fi
Publication of FI82693C publication Critical patent/FI82693C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/723,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems
FI860832A 1985-02-26 1986-02-26 Foerfarande foer framstaellning av som laekemedel anvaendbara substituerade kromanderivat av tiazolidin. FI82693C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP3532485 1985-02-26
JP3532485 1985-02-26
JP3532585 1985-02-26
JP3532585 1985-02-26

Publications (4)

Publication Number Publication Date
FI860832A0 FI860832A0 (fi) 1986-02-26
FI860832A true FI860832A (fi) 1986-08-27
FI82693B FI82693B (fi) 1990-12-31
FI82693C FI82693C (fi) 1991-04-10

Family

ID=26374301

Family Applications (1)

Application Number Title Priority Date Filing Date
FI860832A FI82693C (fi) 1985-02-26 1986-02-26 Foerfarande foer framstaellning av som laekemedel anvaendbara substituerade kromanderivat av tiazolidin.

Country Status (10)

Country Link
US (1) US5104888A (fi)
EP (1) EP0207581B1 (fi)
KR (1) KR930003335B1 (fi)
AU (1) AU588857B2 (fi)
CA (1) CA1256106A (fi)
DE (1) DE3674089D1 (fi)
DK (1) DK173350B1 (fi)
ES (1) ES8802046A1 (fi)
FI (1) FI82693C (fi)
IE (1) IE58853B1 (fi)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873255A (en) * 1987-02-04 1989-10-10 Sankyo Company Limited Thiazolidinone derivatives, their preparation and their use
US5015661A (en) * 1988-08-09 1991-05-14 Hoffmann-La Roche Inc. Chromanes and their pharmaceutical compositions and methods
GB8919417D0 (en) 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
JP2826379B2 (ja) * 1990-01-22 1998-11-18 三共株式会社 チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤
GB9023584D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
FR2680512B1 (fr) * 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
CA2082003A1 (en) * 1991-11-20 1993-05-21 David Laffan Process for the preparation of substituted pentaalkylchromenes
CA2089013A1 (en) * 1992-02-21 1993-08-22 Josef Heveling Process for the preparation of 6-hydroxy-2, 5, 7, 8- tetraalkyl-2-(4-aminophenoxymethyl) chromans
CA2089012A1 (en) * 1992-02-21 1993-08-22 Josef Heveling Process for the preparation of 6-hydroxy-2,5,7,8-tetra- alkyl-2-(4-aminophenoxymethyl) chromans
FR2696743B1 (fr) * 1992-10-12 1994-12-23 Adir Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant.
JP2845743B2 (ja) * 1992-12-28 1999-01-13 三菱化学株式会社 新規なナフタレン誘導体
US5594016A (en) * 1992-12-28 1997-01-14 Mitsubishi Chemical Corporation Naphthalene derivatives
WO1994019347A1 (en) * 1993-02-24 1994-09-01 Sankyo Company, Limited Arteriosclerosis remedy
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
CZ289317B6 (cs) * 1994-04-11 2002-01-16 Sankyo Company Limited Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití
JP3871354B2 (ja) * 1994-07-29 2007-01-24 株式会社フジモト・コーポレーション 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体
CA2159938A1 (en) * 1994-10-07 1996-04-08 Hiroaki Yanagisawa Oxime derivatives, their preparation and their therapeutic use
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5889025A (en) * 1996-05-06 1999-03-30 Reddy's Research Foundation Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
DE19619819A1 (de) * 1996-05-16 1997-11-20 Boehringer Mannheim Gmbh Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltenden Arzneimittel
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
CZ298812B6 (cs) 1996-07-01 2008-02-13 Dr. Reddy's Laboratories Limited Azolidindionové deriváty, způsob jejich přípravy, farmaceutické kompozice s jejich obsahem a jejich použití v léčbě diabetu a příbuzných nemocí
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
FR2760748A1 (fr) * 1997-03-14 1998-09-18 Rhodia Chimie Sa Procede de preparation de 2h-1-benzopyranes
UA67743C2 (uk) 1997-06-18 2004-07-15 Смітклайн Бічам П.Л.С. Фармацевтична композиція, що містить тіазолідиндіон і сульфонілсечовину, для лікування діабету
FR2766820B1 (fr) * 1997-07-31 1999-10-22 Rhodia Chimie Sa Procede de preparation de 2h-1-benzopyranes et intermediaires de synthese utiles dans la mise en oeuvre du procede
AU749505B2 (en) * 1997-10-27 2002-06-27 Dr. Reddy's Laboratories Limited Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
US6444816B1 (en) 1997-10-27 2002-09-03 Dr. Reddy's Research Foundation Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
BR9812770A (pt) 1997-10-27 2000-12-12 Reddy Research Foundation Compostos bicìclicos, processo para seu preparo e composições farmacêuticas contendo os mesmos
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
EP1124807A1 (en) 1997-10-27 2001-08-22 Dr. Reddy's Research Foundation Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
US6265401B1 (en) 1997-10-27 2001-07-24 Reddy-Cheminor, Inc. Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
CN100357281C (zh) * 1998-05-27 2007-12-26 雷迪实验室有限公司 双环化合物、其制备方法和包含它们的药物组合物
AR023699A1 (es) 1998-11-12 2002-09-04 Smithkline Beecham Corp Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica
NZ511614A (en) 1998-11-12 2003-12-19 Smithkline Beecham P Modified release pharmaceutical composition containing the insulin sensitiser 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and the antidiabetic agent metaformin
NZ515284A (en) * 1999-04-28 2004-12-24 Dr Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
AU6016200A (en) * 1999-07-16 2001-02-05 Sankyo Company Limited Coumarone analogues
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US20080207711A1 (en) * 2007-02-28 2008-08-28 Rong Li Method for treating an ID2-related disorder
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
CN102325783A (zh) 2008-12-23 2012-01-18 法莫赛特股份有限公司 嘌呤核苷的合成
PA8855601A1 (es) 2008-12-23 2010-07-27 Forformidatos de nucleósidos
CA2748034A1 (en) * 2008-12-23 2010-07-01 Pharmasset, Inc. Purified 2'-deoxy'2'-fluoro-2'-c-methyl-nucleoside-phosphoramidate prodrugs for the treatment of viral infections
CA2766033C (en) * 2009-06-25 2016-09-20 Alkermes, Inc. Prodrugs of nh-acidic compounds
US10429384B2 (en) 2010-01-22 2019-10-01 Dana-Farber Cancer Institute, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
SG184323A1 (en) 2010-03-31 2012-11-29 Gilead Pharmasett Llc Stereoselective synthesis of phosphorus containing actives
CA2890086C (en) 2012-11-05 2022-05-31 Commissariat A L'energie Atomique Et Aux Energies Alternatives (Cea) Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a stat5 antagonist preferably a thiazolid nedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse
WO2016071727A1 (en) 2014-11-04 2016-05-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the prevention and the treatment of rapidly progressive glomerulonephritis
CA3092335A1 (en) 2018-03-05 2019-09-12 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH619701A5 (fi) 1975-08-07 1980-10-15 Bayer Ag
JPS5522636A (en) 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
DE3010504A1 (de) 1980-03-19 1981-10-01 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 2-hydroxyalkylchromanen
JPS58118577A (ja) * 1982-01-07 1983-07-14 Takeda Chem Ind Ltd チアゾリジン誘導体
JPS58201775A (ja) 1982-05-17 1983-11-24 Kuraray Co Ltd 3,4−ジヒドロ−2h−ベンゾピラン誘導体の製造方法
PT79094B (en) * 1983-08-29 1986-08-14 Salk Inst For Biological Studi Grf analogs
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
JPS6136284A (ja) * 1984-07-27 1986-02-20 Sankyo Co Ltd チアゾリジン誘導体およびその製造方法

Also Published As

Publication number Publication date
FI82693C (fi) 1991-04-10
AU588857B2 (en) 1989-09-28
FI82693B (fi) 1990-12-31
FI860832A0 (fi) 1986-02-26
AU5412286A (en) 1986-09-04
EP0207581B1 (en) 1990-09-12
ES8802046A1 (es) 1988-03-16
DK87886D0 (da) 1986-02-25
US5104888A (en) 1992-04-14
KR860006458A (ko) 1986-09-11
IE58853B1 (en) 1993-11-17
IE860512L (en) 1986-08-26
ES552502A0 (es) 1988-03-16
CA1256106A (en) 1989-06-20
DK87886A (da) 1986-08-27
KR930003335B1 (ko) 1993-04-26
EP0207581A2 (en) 1987-01-07
DE3674089D1 (de) 1990-10-18
DK173350B1 (da) 2000-08-07
EP0207581A3 (en) 1987-07-01

Similar Documents

Publication Publication Date Title
FI860832A0 (fi) Tiazolidinderivat, deras framstaellning och anvaendning.
FI860232A (fi) Tiazolidindionderivat, deras framstaellning och anvaendning.
FI870012A0 (fi) Medelst kopplingsreaktion erhaollna fosforhaltiga amider, deras prekursorer och dessa innehaollande smoerjmedelkompositioner.
FI862644A (fi) Tiazoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar.
FI862029A0 (fi) Askorbinsyraderivat, deras framstaellning och anvaendning.
FI863661A0 (fi) Benzimidazolderivat, deras framstaellning och terapeutiska anvaendning.
FI865264A (fi) Foerfarande foer anvaendning av en spektralskiftskaernreaktor och en kaernreaktor, i vilken anvaends vatten undantraengande knippen.
FI862374A (fi) Foerfarande och anordning foer rundning av plaot, saerskilt foer doskroppar.
FI870734A (fi) Magnetiskt oevervakningssystem foer foeremaol, foerfarande och kodad markoer.
FI863358A (fi) Aminosyra-derivat, foerfarande foer deras framstaellning och anvaendning.
FI864636A (fi) Taetningsdelar, foerslutningar och behaollare.
FI862691A (fi) 2-oxy-4h-3,1-benzoxazin-4-on-derivat och deras foereningar.
FI863480A0 (fi) Azolyl-cyklopropyl-etanolderivat, foerfarande foer deras framstaellning och deras anvaendning.
FI862478A (fi) Vattenbaserade, filmbildande oeverdragskompositioner och deras anvaendning.
FI860870A0 (fi) Antibakteriska foereningar, deras framstaellning och anvaendning.
FI853787L (fi) Elektronisk fjaerrstyrnings- och fjaerrmaetningssystem, speciellt foer foerutsaegning och styrning av foeroreningsaemnen.
FI871428A0 (fi) Framstaellning av allylamin och, utgaoende fraon denna, kvaternaera diallylammoniumfoereningar.
FI853621L (fi) Vinyltetrasolylfenyl-derivat, deras framstaellning och anvaendning.
FI864566A (fi) Nitroantracykliner, foerfarande foer deras framstaellning och deras anvaendning.
FI862851A (fi) Morfoliniokarboxylsyraester- och morfolinioalkylfenyletersalter, deras framstaellningsfoerfarande och deras anvaendning saosom fungicider.
FI865240A0 (fi) Reaktionsfaergaemnen, deras framstaellning och anvaendning.
FI863794A0 (fi) Alkenylazoler, foerfaranden foer deras framstaellning och deras anvaendning.
FI861115A0 (fi) Imidazo-isokinoliner och imidazo-tienopyridinfoereningar, laekemedel innehaollande dessa foereningar och foerfarande foer deras framstaellning.
FI861884A0 (fi) Foerfaringssaett foer framstaellning av en gjutmassa, innehaollande vattenglas och eventuellt kvarts.
FI860456A (fi) Bis-indolalkaloiders proteinkonjugat, bis-indolalkaloider, deras framstaellning och anvaendning.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANKYO COMPANY LIMITED